TuesdayMay 03, 2011 5:21 pm

New Leaf Brands, Inc. (NLEF) Signs Digital Marketing Agreement

The focus of New Leaf Brands Inc. is to provide consumers with great tasting, healthy beverages. New Leaf Tea is the company's first product line and comes in 14 unique flavors including white, black, blue, and green teas along with four lemonade flavors. The company announced today that it has signed an agreement with Lone Wolf Inc. (LWI), a business development firm specializing in social and digital media marketing. Lone Wolf will help New Leaf Brands take the next step into the digital and social era. New Leaf Brands has already taken some steps along that path. It is well…

Continue Reading

TuesdayMay 03, 2011 5:18 pm

BioNeutral Group, Inc. (BONU) Aligning for Growth

BioNeutral Group has had an influx of developments over the last few months. Not only has the Company received Environmental Protection Agency approval for Ygiene® 206, its hospital grade disinfectant, but sales are coming in for its odor neutralizer and multipurpose cleaning unregulated product line, Ogiene®. Equally important, some key milestones have been reached recently. Local U.S. contract manufacturing is under agreement covering both the Ygiene® and Ogiene® technology platforms with the initial 1,000 gallon shipment of Ogiene® products having been manufactured and shipped to Kentucky in advance of initial orders. State approvals are coming in and select municipal vendor…

Continue Reading

TuesdayMay 03, 2011 4:46 pm

Metropolitan Health Networks Inc. (MDF) Posts Q1 Earnings and 2011 Expansion Strategy

Metropolitan Health Networks Inc., a leading provider of health care services in Florida, today announced the financial results for their first quarter ended March 31, 2011, reflecting the company’s focus on outward growth for fiscal 2011. The company recognized revenue of $94.7 million for the first quarter of 2011, a 1.8 percent increase compared to $93 million in the first quarter of 2010. Net income for the first quarter was $8.0 million, or $0.20 per basic share and $0.19 diluted, as compared to $7.1 million, or $0.18 per basic share and $0.17 diluted, for the same quarter last year. As…

Continue Reading

TuesdayMay 03, 2011 4:45 pm

Adeona Pharmaceuticals, Inc. (AEN) Receives Additional $1.5 Million for MS Drug Clinical Trial

The National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) has given $1,594,553 in grant funding to Adeona Pharmaceuticals, Inc. for the ongoing clinical trial of its TrimestaTM drug (oral estriol) for the treatment of multiple sclerosis. The company recently received a grant of $409,426 from the National Multiple Sclerosis Society (NMSS) also in support of the Trimesta clinical trial. This is in addition to earlier grants for the trial, including $5 million from the NMSS in partnership with the NMSS’s Southern California Chapter, with support from the National Institutes of Health, and $860,440 from the American Recovery…

Continue Reading

TuesdayMay 03, 2011 3:42 pm

Kulicke & Soffa Industries Inc. (KLIC) Posts Q2 Results and Strong Q3 Guidance

Kulicke & Soffa Industries Inc., a leading designer and manufacturer of LED assembly equipment, today announced results for its second fiscal quarter ended April 2, 2011. For its second quarter of fiscal 2011, the company reported net revenue of $206.7 million, up 34.4 percent from the comparable quarter of last year. Net income gained 88.5 percent at $39.9 million, or $0.54 per diluted share. Bruno Guilmart, Kulicke & Soffa’s president and CEO, said the company’s second-quarter performance surpassed previous expectations and reflects solid demand for its equipment. “Our results exceeded the high-end of prior guidance, with revenue increasing approximately 39…

Continue Reading

TuesdayMay 03, 2011 1:38 pm

Metropolitan Health Networks Inc. (MDF) Posts Q1 Earnings and 2011 Expansion Strategy

Metropolitan Health Networks Inc., a leading provider of health care services in Florida, today announced the financial results for their first quarter ended March 31, 2011, reflecting the company’s focus on outward growth for fiscal 2011. The company recognized revenue of $94.7 million for the first quarter of 2011, a 1.8 percent increase compared to $93 million in the first quarter of 2010. Net income for the first quarter was $8.0 million, or $0.20 per basic share and $0.19 diluted, as compared to $7.1 million, or $0.18 per basic share and $0.17 diluted, for the same quarter last year. As…

Continue Reading

TuesdayMay 03, 2011 1:37 pm

Northwest Biotherapeutics, Inc. (NWBO) Launches Cross-country Enrollment for Promising Brain Cancer Treatment

Northwest Biotherapeutics, a biotech company focused on immunotherapy products to treat cancer without toxicities associated with chemotherapies, today announced it has begun enrollment of new patients in the company's ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax® immune therapy for Glioblastoma multiforme (GBM), the most fatal type of brain cancer. So far the company has enrolled 33 patients for the cancer trial and its information arm; patients are already receiving treatment regimen and follow-up. Four recruiting centers are carrying out the company’s enrollment initiatives: the University of Rochester in New York; the University Hospitals of Cleveland in…

Continue Reading

TuesdayMay 03, 2011 1:34 pm

EcoloCap Solutions Inc. (ECOS) Announces Distribution Agreement with Nano-Tech Industries Pty Ltd.

EcoloCap Solutions Inc., an operator of an integrated and complementary network of environmentally focused companies that use nanotechnology for alternative energy, announced that it has entered into an exclusive distribution agreement with Nano-Tech Industries Pty Ltd, of Acacia Ridge, Australia. After copious amounts of testing for M-Fuel confirmed the reduction in emissions as well as its cost effectiveness, Nano-Tech Technologies Pty Ltd, agreed to utilize their network to deploy all EcoloCap products in Australia, New Zealand, and the Pacific Islands. The NPU processor produces approximately 18,000 gallons of emulsion fuel per day and is even capable of emulsifying Diesel, Kerosene,…

Continue Reading

TuesdayMay 03, 2011 12:00 pm

Adeona Pharmaceuticals, Inc. (AEN) Receives Additional $1.5 Million for MS Drug Clinical Trial

The National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) has given $1,594,553 in grant funding to Adeona Pharmaceuticals, Inc. for the ongoing clinical trial of its TrimestaTM drug (oral estriol) for the treatment of multiple sclerosis. The company recently received a grant of $409,426 from the National Multiple Sclerosis Society (NMSS) also in support of the Trimesta clinical trial. This is in addition to earlier grants for the trial, including $5 million from the NMSS in partnership with the NMSS’s Southern California Chapter, with support from the National Institutes of Health, and $860,440 from the American Recovery…

Continue Reading

TuesdayMay 03, 2011 10:08 am

Altair Nanotechnologies, Inc. (ALTI) Video Chart for Tuesday, May 3, 2011

ALTI appears to be trying to form a bottom. The indicators are trying to uptrend and the price per share has made a higher low. The resistance level at $1.58 will be a key point to break for continued upward movement. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered